Pure Global AI
ANVISA registration 10338930315Active

ANTI-INFLIXIMAB (IFX) ANTIBODIES

ANVISA Registration Number: 10338930315EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDABIOSYNEX SARisk Class II
Verified
Device names
Technical name
ANTI-INFLIXIMAB (IFX) ANTIBODIES
View exact technical-name matches →
PT: ANTICORPOS ANTI-INFLIXIMAB (IFX)
Commercial name
LISA-TRACKER ANTI-INFLIXIMAB
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10338930315
Process Number
25351369547202453
CNPJ
93741726000166
Company information
Registration Holder
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
Manufacturer
BIOSYNEX SA
Manufacturing Country
France
PT: FRANÇA
Dates and status
Publication Date
Jul 22, 2024
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930315 and manufactured by BIOSYNEX SA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.